Evidence map›Paper›PMID 37239145›Full record

ArticleBiomedicines2023

New Opportunities for Preoperative Diagnosis of Medullary Thyroid Carcinoma.

Sergei A Lukyanov, Sergei V Sergiyko, Sergei E Titov, Dmitry G Beltsevich, Yulia A Veryaskina, Vladimir E Vanushko, Liliya S Urusova, Alexander A Mikheenkov, Evgeniya S Kozorezova, Sergey L Vorobyov and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Histopathology of C Cells and Medullary Thyroid Carcinoma.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2025
    Review
  4. Article
  5. CouldDiagnostics (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Sergei A LukyanovDepartment of General Surgery, South Ural State Medical University, 454092 Chelyabinsk, Russia.ORCID 0000-0001-5559-9872
Sergei V SergiykoDepartment of General Surgery, South Ural State Medical University, 454092 Chelyabinsk, Russia.
Sergei E TitovLaboratory of Molecular Genetics, Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0001-9401-5737
Dmitry G BeltsevichDepartment of Surgery, National Medical Research Center for Endocrinology, 115478 Moscow, Russia.
Yulia A VeryaskinaLaboratory of Gene Engineering, Institute of Cytology and Genetics, SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0002-3799-9407
Vladimir E VanushkoDepartment of Surgery, National Medical Research Center for Endocrinology, 115478 Moscow, Russia.
Liliya S UrusovaDepartment of Surgery, National Medical Research Center for Endocrinology, 115478 Moscow, Russia.ORCID 0000-0001-6891-0009
Alexander A MikheenkovDepartment of Surgery, National Medical Research Center for Endocrinology, 115478 Moscow, Russia.
Evgeniya S KozorezovaDepartment of Cytopathology, National Center for Clinical Morphological Diagnostics, 192071 Saint Petersburg, Russia.ORCID 0000-0002-3659-7510
Sergey L VorobyovDepartment of Cytopathology, National Center for Clinical Morphological Diagnostics, 192071 Saint Petersburg, Russia.
Ilya V SleptsovDepartment of Endocrinology and Endocrine Surgery, Saint Petersburg State University N.I. Pirogov Clinic of High Medical Technologies, 190121 Saint Petersburg, Russia.
Chelyabinsk State Medical Academy · RUInstitute of Cytology and Genetics · RUNovosibirsk State University · RUSt Petersburg University · RU

Funding

Institute of Molecular and Cell Biology FWGZ-2021-0014Ministry of Science and Higher Education (Russia) 121040100268-9
6 · The paper itself

Abstract

The preoperative diagnostics of medullary thyroid carcinoma (MTC), including the measuring of the blood calcitonin level, has a number of limitations. Particular focus has recently been placed on the role of miRNAs in the development of various malignant tumors; a comparative analysis of accuracy of the existing methods for MTC diagnosis with a novel diagnosis method, evaluation of the miRNA-375 expression level, was performed in this study. The expression level of miRNA-375 in cytology samples from 555 patients with the known histological diagnosis, including 41 patients with confirmed postoperative diagnosis of MTC, was assessed. The diagnostic parameters of the basal calcitonin level, calcitonin in wash-out fluid from the FNAB needle, and miRNA-375 were compared. An assessment of the miRNA-375 expression level made it possible to detect all the MTC samples with a 100% accuracy among all the 555 cytology specimens, as well as in non-informative FNAB specimens, and specimens from the ipsilateral thyroid lobe. Parameters such as sensitivity, specificity, PPV, and NPV were 100%. The miRNA-375 level, unlike calcitonin, does not correlate with tumor volume, so it does not have the so-called "gray zone". An assessment of the miRNA-375 expression allows one to accurately distinguish MTC from other malignant and benign thyroid tumors.

Indexed as

calcitoninfine-needle aspiration samplesmedullary thyroid carcinomamiRNA-375molecular testing

Identifiers

PMID37239145
PMCPMC10216661
OpenAlexW4377020322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.